Mankind Pharma Limited has announced the successful completion of the amalgamation of three of its group companies—Shree Jee Laboratory Private Limited, JPR Labs Private Limited, and Jaspack Industries Private Limited—with itself. The merger has become effective from March 29, 2025, following the filing of necessary forms with the Registrar of Companies (ROC).
The Scheme of Arrangement was earlier approved by the National Company Law Tribunal (NCLT), New Delhi Bench, on February 25, 2025, and the certified copy of the order was received on March 12, 2025. As per Clause 1.7 of the Scheme, the effective date is the day on which the certified order is filed with the ROC.
With this merger, all assets and liabilities of the transferor companies now stand transferred to Mankind Pharma. Additionally, the authorized share capital of the transferor entities has been merged with that of Mankind Pharma. Following the merger, the revised authorized capital of the company now stands at Rs 421.51 crore, comprising equity shares and optionally convertible preference shares.
The merger aims to streamline operations and enhance synergy across the group entities.
Disclaimer: The information provided in this article is based on official disclosures made by the company to stock exchanges. It is intended solely for informational purposes and should not be construed as financial or investment advice. Stock market investments are subject to market risks. Readers are advised to consult with a qualified financial advisor before making any investment decisions. Neither the author nor the publication is responsible for any losses incurred based on the information provided.
